Evaluation of Long-term HPV Vaccine Efficacy
A Long-term Follow-up Registry-based Cohort Study of HPV Vaccine Efficacy Against Cervical Pre-cancerous Lesions and Cervical Cancers in a Cohort of Females Previously Enrolled From Finland in Study HPV-008, as Compared to a Non-intervention Population -Based Reference Cohort of Females From Finland
Sponsor: FinnMedi Oy
This observational or N/A phase trial investigates Uterine Cervical Cancer and is currently ongoing. FinnMedi Oy leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Jan 2025 — Present [monthly]
Unknown
Status: Enrolling By Invitation → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Dec 2021 — Jul 2024 [monthly]
Enrolling By Invitation
-
Jan 2021 — Dec 2021 [monthly]
Enrolling By Invitation
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Apr 2019 — Nov 2020 [monthly]
Enrolling By Invitation
-
Jun 2018 — Apr 2019 [monthly]
Enrolling By Invitation
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — May 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Aug 2017 [monthly]
Enrolling By Invitation NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- FinnMedi Oy
- GlaxoSmithKline
- Tampere University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Helsinki, Finland , Jyväskylä, Finland , Kotka, Finland , Kouvola, Finland , Kuopio, Finland , Lahti, Finland , Lappeenranta, Finland , Mikkeli, Finland , Oulu, Finland , Pori, Finland and 5 more locations